Publications:

Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report.

Bmc Research Notes

Meyer zu Schwabedissen, Henriette E HE; Siegmund, Werner W; Kroemer, Heyo K HK; Rollnik, Jens D JD

Publication Date: 2014-10-03

Variant appearance in text: CYP2C9: 699A>G

PubMed Link: 25280537

Variant Present in the following documents:

• Main text
• 13104_2014_Article_3210.pdf

View BVdb publication page